ANN ARBOR — Synthetic Biologics Inc. (NYSE Amex: SYN) Thursday announced the release of its investor relations mobile iPhone App, called the “SYN IR” App, now available for free at the Apple App Store on the iPhone or iPad or at

The Synthetic Biologics’ investor relations mobile iPhone App allows users to navigate the Company’s investor relations materials as well as receive a stock quote and other important stock information. Features in the “SYN IR” App include the latest press releases and SEC filings as well as a corporate fact sheet and listing of events.

“The launch of our investor relations iPhone App provides our current and potential shareholders with immediate access to financial and corporate information regarding the Company,” stated C. Evan Ballantyne, CFO at Synthetic Biologics. “With investors always on the move and spanning the globe, we recognize the growing importance of mobile technology. This new application allows our shareholders to have instant access to our corporate and stock information. We are excited to be one of the early adopters of mobile technology that is intended to help drive shareholder value and create broader awareness throughout the investment community.”

Synthetic Biologics is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. Synthetic Biologics is developing, or has partnered the development of, product candidates for the treatment of pulmonary arterial hypertension (PAH), relapsing-remitting multiple sclerosis, cognitive dysfunction in MS, fibromyalgia and amyotrophic lateral sclerosis. For more information, please visit Synthetic Biologics’ Web site at